VIVOS THERAPEUTICS, INC. (VVOS) Operating cash flow 2019–2025
VIVOS THERAPEUTICS, INC. (VVOS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$15.3MFY2025 · since FY2019: -$5.3M → -$15.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.3M | -20.3% |
| FY2024 | -$12.7M | -6.2% |
| FY2023 | -$11.9M | +39.0% |
| FY2022 | -$19.6M | -24.5% |
| FY2021 | -$15.7M | -177.0% |
| FY2020 | -$5.7M | -6.4% |
| FY2019 | -$5.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VVOS financial trends
VVOS RevenueVVOS Net incomeVVOS Net marginVVOS Gross profitVVOS Gross marginVVOS Operating incomeVVOS Operating marginVVOS Free cash flowVVOS Capital expendituresVVOS Return on equityVVOS Stock buybacksVVOS Dividends paidVVOS Total assetsVVOS Total liabilitiesVVOS Shareholders’ equityVVOS overview →